saxenda

Generic: liraglutide

Labeler: novo nordisk
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name saxenda
Generic Name liraglutide
Labeler novo nordisk
Dosage Form INJECTION, SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

liraglutide 6 mg/mL

Manufacturer
Novo Nordisk

Identifiers & Regulatory

Product NDC 0169-2800
Product ID 0169-2800_eba7f5c9-44d0-4549-ae94-daa2c5181646
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA206321
Listing Expiration 2027-12-31
Marketing Start 2014-12-31

Pharmacologic Class

Established (EPC)
glp-1 receptor agonist [epc]
Mechanism of Action
glucagon-like peptide-1 (glp-1) agonists [moa]
Chemical Structure
glucagon-like peptide 1 [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01692800
Hyphenated Format 0169-2800

Supplemental Identifiers

UNII
839I73S42A
NUI
N0000178480 M0160181 N0000020058

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name saxenda (source: ndc)
Generic Name liraglutide (source: ndc)
Application Number NDA206321 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 6 mg/mL
source: ndc
Packaging
  • 5 SYRINGE, PLASTIC in 1 CARTON (0169-2800-15) / 3 mL in 1 SYRINGE, PLASTIC
  • 1 SYRINGE, PLASTIC in 1 CARTON (0169-2800-90) / 3 mL in 1 SYRINGE, PLASTIC
  • 1 SYRINGE, PLASTIC in 1 CARTON (0169-2800-97) / 3 mL in 1 SYRINGE, PLASTIC
source: ndc

Packages (3)

0169-2800-15 5 SYRINGE, PLASTIC in 1 CARTON (0169-2800-15) / 3 mL in 1 SYRINGE, PLASTIC 0169-2800-90 1 SYRINGE, PLASTIC in 1 CARTON (0169-2800-90) / 3 mL in 1 SYRINGE, PLASTIC 0169-2800-97 1 SYRINGE, PLASTIC in 1 CARTON (0169-2800-97) / 3 mL in 1 SYRINGE, PLASTIC

Ingredients (1)

liraglutide (6 mg/mL)

Linked Drug Pages (1)

Saxenda ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "eba7f5c9-44d0-4549-ae94-daa2c5181646", "openfda": {"nui": ["N0000178480", "M0160181", "N0000020058"], "unii": ["839I73S42A"], "spl_set_id": ["3946d389-0926-4f77-a708-0acb8153b143"], "pharm_class_cs": ["Glucagon-Like Peptide 1 [CS]"], "pharm_class_epc": ["GLP-1 Receptor Agonist [EPC]"], "pharm_class_moa": ["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "manufacturer_name": ["Novo Nordisk"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "5 SYRINGE, PLASTIC in 1 CARTON (0169-2800-15)  / 3 mL in 1 SYRINGE, PLASTIC", "package_ndc": "0169-2800-15", "marketing_start_date": "20150119"}, {"sample": false, "description": "1 SYRINGE, PLASTIC in 1 CARTON (0169-2800-90)  / 3 mL in 1 SYRINGE, PLASTIC", "package_ndc": "0169-2800-90", "marketing_start_date": "20150119"}, {"sample": false, "description": "1 SYRINGE, PLASTIC in 1 CARTON (0169-2800-97)  / 3 mL in 1 SYRINGE, PLASTIC", "package_ndc": "0169-2800-97", "marketing_start_date": "20150119"}], "brand_name": "Saxenda", "product_id": "0169-2800_eba7f5c9-44d0-4549-ae94-daa2c5181646", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["GLP-1 Receptor Agonist [EPC]", "Glucagon-Like Peptide 1 [CS]", "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "product_ndc": "0169-2800", "generic_name": "liraglutide", "labeler_name": "Novo Nordisk", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Saxenda", "active_ingredients": [{"name": "LIRAGLUTIDE", "strength": "6 mg/mL"}], "application_number": "NDA206321", "marketing_category": "NDA", "marketing_start_date": "20141231", "listing_expiration_date": "20271231"}